Log on / register
Feedback | Support | My details

Comments

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

Kyung-Hun Lee email, Seock-Ah Im email, Do-Youn Oh email, Se-Hoon Lee email, Eui Kyu Chie email, Wonshik Han email, Dong-Wan Kim email, Tae-You Kim email, In Ae Park email, Dong-Young Noh email, Dae Seog Heo email, Sung Whan Ha email and Yung-Jue Bang email

BMC Cancer 2007, 7:63doi:10.1186/1471-2407-7-63

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.